| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Oncology [L. H. A., G. M. A., T. L. C., B. G. H.], Cell Biology [W. E.], and Molecular Genetics [R. K], Albert Einstein Cancer Center, Montefiore Hospital, 111 East 210th Street, Bronx, New York 10467, and Strang Cancer Prevention Center, 1230 York Avenue, New York, New York 10021 [K. Y., M. L.]
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Reports from our laboratory have established that the induction of differentiation, growth arrest, and apoptosis of colonic cells in culture by SCFAs is linked to their efficient metabolism (6 , 7) . Thus, we hypothesized that the elimination of efficient SCFA metabolism would interfere with this pathway and reduce apoptosis in the gastrotintestinal tract. Moreover, because it has been reported that such reductions in apoptosis characterize the mucosa in mice and in humans that inherit a mutant Apc allele (13 , 14) , we further hypothesized that this would provide a means of determining the contribution of altered apoptosis in the gastrointestinal mucosa to Apc-initiated tumorigenesis.
To test this hypothesis, we generated mice in which tumors were initiated by the inheritance of a mutant Apc allele but that were inefficient in their metabolism of SCFAs due to a homozygous deletion of the gene that encodes Scad, the first enzyme in the mitochondrial B-oxidation of SCFAs. Although the deletion of the Scad gene indeed had dramatic affects on the utilization of SCFAs as an energy source and apoptosis in the duodenum and proximal and distal colon, this had no effect on tumorigenesis. Moreover, although there were modest alterations in tumor formation in the jejunum in mice that were fed a normal or fiber-supplemented diet, there was no alteration in the frequency of apoptotic cells at this site. Therefore, the data strongly support the hypothesis that SCFAs, through their role as an energy source, play a role as modulators of apoptosis in the gastrointestinal tract. However, coupled with reports from our laboratory and others that there are no alterations in apoptosis in the Apc1638N+/- mouse in which an inherited Apc mutation leads to gastrointestinal tumorigenesis, the data do not support a role for a general decrease in apoptosis in the mucosa in initiating tumorigenesis by a mutant Apc allele.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The BALB/cByJ strain, obtained from The Jackson Laboratory, has a homozygous deletion of the gene that encodes short-chain acyl dehydrogenase (17) . This locus was termed Bcd-1, and the gene has more recently been referred to as Scad (18) . Scad -/- mice are deficient in SCFA metabolism (18 , 19) . These mice were mated with Apc1638N+/- mice to generate offspring that were Apc+/-, Scad+/-. Crosses between these animals then generated litter mates that were Apc+/- and either Scad+/+ or Scad-/-. DNA from tail clips were analyzed for the presence of the Apc and Scad mutations, as described (15 , 20) , and the mice were randomized to different dietary groups. Mice were killed after 36 weeks on the AIN76A diet or on this diet supplemented with 120 g/Kg hard red wheat bran (Harlan-Teklad, Madison, WI). The wheat bran was added at the expense of cellulose in the diet. The entire gastrointestinal tract was analyzed for tumors as described previously (15 , 16) .
Mice were maintained under the supervision of a veterinarian, and experimental protocols were approved by the Institutional Animal Care and Use Committee in accord with NIH guidelines for the use and care of animals.
Apoptosis and Proliferation.
Animals were killed by CO2 inhalation, and the GI tract was rapidly dissected. Portions of the intestinal tract were placed in 10% formalin for no longer than 24 h. The tissues were then transferred to 80% and then 95% ethanol, each for 1824 h, before embedding in paraffin. Sections were cut at 4-µm thickness. Apoptotic cells were evaluated by TUNEL using the kit from Trevigen (Gaithersburg, MD). Briefly, we adhered to the following protocol: formalin fixation was strictly limited to no more than 24 h; after deparaffinization and rehydration of the sections, proteinase K digestion was limited to 10 min; the sections were immersed in 3% H2O2 in 40% methanol for no more than 5 min to quench endogenous peroxidase activity. After incorporation of biotin-labeled dUTP into 3' ends of fragmented DNA, and complex formation with streptavidin-horseradish peroxidase, reaction with freshly prepared diaminobenzidine for color development was done in the presence of 0.4 mM MnCl2 for no more than 10 min. Sections were finally counterstained lightly with methyl green. For the detection of PCNA, a kit from Zymed (South San Francisco, CA) was used, according to the manufacturers protocol. The scoring of both TUNEL- and PCNA-positive cells was done at x 400.
For each animal, at least 500 cells were scored in well-oriented crypts and villi of the proximal and distal colon and of the duodenum. For colonic sections, data are expressed as percent of crypt cells positive, whereas for duodenum (and jejunum), it is the percent of total crypt and villus cells that are positive.
| RESULTS |
|---|
|
|
|---|
|
|
|
Fig. 1
illustrated that mice fed the high fiber diet could use the SCFAs generated in the colon as an additional energy source, and that this was eliminated by the Scad mutation. Similar to the mice fed the basal AIN76A diet, mice fed the wheat bran diet showed the same pattern of reduction of apoptosis in the colon in the absence of ability to metabolize SCFAs. Apoptosis was again reduced by >80% (P < 0.03) in the proximal colon, with a smaller reduction that was not significant (P < 0.10) in the distal colon (Fig. 4)
. In contrast to the basal diet, there was no reduction in apoptosis in the duodenum for the mice on the wheat bran diet (Fig. 4)
.
|
The data in Table 1
demonstrate that for the mice on the AIN76A diet, the elimination of SCFA metabolism, and hence significant reduction in apoptosis in the mucosa, did not have an effect on tumor incidence or number. Further, Fig. 5
(top) illustrates that the homozygous deletion of the Scad gene did not change the site specificity of tumor formation in the gastrointestinal tract initiated by the Apc mutation. As previously reported, the majority of tumors in the Apc1638N+/- mice were in the small intestine, principally in the duodenum (15
, 16)
, and tumor incidence was not affected by the decrease in apoptosis in the duodenum associated with the homozygous deletion of the Scad gene. Most important, however, was that the nearly complete elimination of apoptotic cells in the proximal colon by the Scad mutation (Fig. 3)
, did not cause tumors to form at this site, although there was an initiating Apc mutation (Fig. 5
(top)).
|
|
For both diets, there were somewhat more tumors in the jejunum for the Scad-/- group compared with the wild type Scad mice. We therefore investigated whether there were alterations in apoptosis at this site. Fig. 6
illustrates that the percent apoptotic cells in the jejunum was not altered by the Scad mutation in either diet group.
|
| DISCUSSION |
|---|
|
|
|---|
(a) the data demonstrate that SCFAs derived from fermentation of fiber can be a significant energy source. This is concluded from the increased weight gain in the mice fed the wheat-bran-supplemented diet and the fact that the weight gain was eliminated by the Scad mutation, which prevents efficient SCFA metabolism;
(b) frequency of apoptosis in the gastrointestinal tract is influenced by SCFA metabolism. The elimination of efficient B-oxidation of SCFAs in the gastrointestinal tract of mice by homozygous deletion of the Scad gene (17, 18, 19) almost completely eliminated apoptosis in the proximal colon and decreased apoptosis in the distal colon in mice fed either AIN76A or a wheat-bran supplemented diet. Decreased apoptosis in the duodenum was also seen in the mice that were fed AIN76A. This supports our hypothesis, based on extensive work we have published elsewhere (6 , 7) , that the efficient metabolism of SCFAs is necessary for their stimulation of an apoptotic pathway in colonic epithelial cells in vitro. It also supports the conclusion from the work of others that pathways induced by SCFAs in vitro also function in vivo, through the role of SCFAs as the principal energy source for colonic epithelial cells (3, 4, 5, 6, 7, 8, 9, 10, 11, 12) . Thus, metabolic activity of the cell can have an important influence on frequency with which cells enter and complete an apoptotic pathway;
(c) the frequency of apoptosis in the mucosa of the gastrointestinal tract is not directly related to the frequency of tumor formation due to an inherited mutation of the Apc gene. This is demonstrated by the fact that the reduction of apoptotic cells in the duodenum of mice on the AIN76A diet did not increase tumor formation at this site and, most important, that the almost complete elimination of apoptotic cells in the proximal colon in mice fed AIN76A or wheat-bran diet was insufficient to produce tumors at that site. Moreover, although there were modest alterations in tumor formation in the jejunum in the Apc-initiated Scad mutant mice on either diet, there was no change in the frequency of apoptotic cells at this site.
There are conflicting data in the literature regarding whether an inherited Apc mutation leads to tumor formation through an alteration in frequency of apoptosis. Consistent with the work of others (21, 22, 23)
, we have reported that the percentage of apoptotic cells in the gastrointestinal mucosa of the mouse is low, as illustrated in Figs. 2
3
4
. At 15 weeks of age, approximately 4% of the cells in the duodenum, 2% in the proximal colon, and 1% in the distal colon are detected as apoptotic when scored by TUNEL assay done as described in "Materials and Methods." These values decrease with age and are not altered by the presence of the Apc mutation in Apc1638N mice (24
, 25)
. This low incidence of apoptotic cells is similar to values reported using morphological criteria in the mouse (21)
and rat (23)
and using TUNEL in the rat (22)
. Moreover, in Apc1638 mice, we score a similar incidence of apoptosis, and lack of change in apoptosis, in the gastrointestinal tract compared with control, whether apoptotic cells are recognized by TUNEL assay (24
, 25) or by morphology in H&E-stained sections (27)
.
It was recently confirmed that the inherited Apc mutation in Apc1638N does not alter apoptosis in the small intestine (28)
. However, that report also reiterated previous work from the same group that, in contrast, ApcMin+/- mice do exhibit a decrease in apoptosis (14
, 29
, 30)
. This was attributed to a dominant-negative effect of the Apc mutation in ApcMin and the absence of such an effect of the different mutation in Apc1638N (28)
. Moreover, it was suggested that this dominant-negative effect on reducing apoptosis in the mucosa of ApcMin was the cause of the much greater number of tumors that form in ApcMin compared with Apc1638N (28)
. There are three critical points, however, that should be noted regarding this conclusion. First, the data presented here demonstrate that reduction of apoptosis in the duodenum and nearly complete elimination of apoptosis in the proximal colon were insufficient to increase tumor formation in the mouse gastrointestinal tract. Therefore, because ApcMin and Apc1638N differ by more than an order of magnitude in frequency of tumor formation, the two strains must differ in fundamental aspects affecting tumorigenesis other than affects on apoptosis. Second, the Apc
716 mouse has a mutation in codon 716 of Apc, similar to the position of the mutation at codon 850 of Apc in ApcMin (31
, 32)
, and both Apc
716 and ApcMin exhibit much higher levels of tumor formation than does Apc1638N. However, evidence has been reported that tumor formation in Apc
716 always involves loss of the wild-type Apc allele in even the smallest microdissected tumors, and that the
716 mutation has no dominant-negative effect (31
, 32)
. Thus, the data suggesting that there is a decrease in apoptosis in the flat mucosa of ApcMin mice due to a dominant-negative effect of the inherited mutant allele should be examined. In this regard, publications from the group that suggest a dominant-negative affect in ApcMin on apoptosis reported levels of apoptosis in control animals of 3550% (14
, 29
, 30)
. This is an order of magnitude higher than that reported by others and is in contrast to lower levels that they have recently reported (28)
. Moreover, such extensive apoptosis is not a feature of the histology of the gastrointestinal tract and is difficult to reconcile with the normal function of the mucosa and with the growth and development of the animals. This discrepancy has not been addressed.
The data presented raise one final point. A recent large epidemiological study has demonstrated that individuals consuming higher amounts of vegetable fiber exhibited a statistically significant increase in gastrointestinal tumors (33) . It is interesting that in our study, wheat-bran fiber increased tumor formation in these genetically initiated mice but only in those animals incapable of B-oxidation of SCFAs (i.e., Scad mutant mice). We have found that levels of mitochondrial gene expression in rectal biopsies vary over a wide range in the human population, but that the level is stable for each patient when assayed in serial biopsies taken over six months.5 If this reflects altered mitochondrial function, then one might speculate that the epidemiological linkage of dietary fibers and, potentially, other dietary constituents to tumorigenesis would be stronger if one factored in mitochondrial function as a variable.
In summary, we conclude that SCFAs derived from fiber fermentation in the gastrointestinal tract are an additional energy source, and that alterations in SCFA metabolism can substantially modulate levels of apoptosis in the gastrointestinal tract, especially in the proximal colon, the site at which these compounds are produced by microbial fermentation and at which they are at highest concentration. However, these reductions in apoptosis did not alter tumorigenesis initiated by an inherited Apc mutation. This finding and the lack of alteration in apoptosis in the gastrointestinal mucosa in Apc1638N+/- mice compared with control do not support the hypothesis that Apc initiates tumorigenesis by causing a general decrease of apoptosis in the mucosa.
| FOOTNOTES |
|---|
1 Supported in part by Grant 95B025 from the American Institute for Cancer Research and Grants CA75246, CA67944, CA76329, and P30-13330 from the National Cancer Institute. ![]()
2 To whom requests for reprints should be addressed, at Department of Oncology, Albert Einstein Cancer Center, Montefiore Hospital, 111 East 210th Street, Bronx, NY 10467. Phone: (718) 920-4663; Fax: (718) 882-4464; E-mail: augen{at}aecom.yu.edu ![]()
3 The abbreviations used are: SCFA, short-chain fatty acid; Apc, adenomatous polyposis coli; Scad, short-chain acyl dehydrogenase; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end labeling; PCNA, proliferating cell nuclear antigen. ![]()
5 L. H. Augenlicht and P. Holt, unpublished data. ![]()
Received 6/23/99. Accepted 10/ 4/99.
| REFERENCES |
|---|
|
|
|---|

mt) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res., 58: 2869-2875, 1998.This article has been cited by other articles:
![]() |
K. Yang, S. A. Lamprecht, H. Shinozaki, K. Fan, W. Yang, H. L. Newmark, L. Kopelovich, W. Edelmann, B. Jin, C. Gravaghi, et al. Dietary Calcium and Cholecalciferol Modulate Cyclin D1 Expression, Apoptosis, and Tumorigenesis in Intestine of adenomatous polyposis coli1638N/+ Mice J. Nutr., September 1, 2008; 138(9): 1658 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khare, C. Holgren, and A. M. Samarel Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2 Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1100 - G1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzanti, M. Solazzo, O. Fantappie, S. Elfering, P. Pantaleo, P. Bechi, F. Cianchi, A. Ettl, and C. Giulivi Differential expression proteomics of human colon cancer Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1329 - G1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Heerdt, M. A. Houston, and L. H. Augenlicht The Intrinsic Mitochondrial Membrane Potential of Colonic Carcinoma Cells Is Linked to the Probability of Tumor Progression Cancer Res., November 1, 2005; 65(21): 9861 - 9867. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L. H. Augenlicht Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice Am. J. Pathol., April 1, 2005; 166(4): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyauchi, E. Gopal, Y.-J. Fei, and V. Ganapathy Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids J. Biol. Chem., April 2, 2004; 279(14): 13293 - 13296. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Heerdt, M. A. Houston, A. J. Wilson, and L. H. Augenlicht The Intrinsic Mitochondrial Membrane Potential ({Delta}{psi}m) Is Associated with Steady-State Mitochondrial Activity and the Extent to Which Colonic Epithelial Cells Undergo Butyrate-mediated Growth Arrest and Apoptosis Cancer Res., October 1, 2003; 63(19): 6311 - 6319. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Augenlicht, A. Velcich, L. Klampfer, J. Huang, G. Corner, M. Aranes, C. Laboisse, B. Rigas, M. Lipkin, K. Yang, et al. Application of Gene Expression Profiling to Colon Cell Maturation, Transformation and Chemoprevention J. Nutr., July 1, 2003; 133(7): 2410S - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Augenlicht, J. M. Mariadason, A. Wilson, D. Arango, W. Yang, B. G. Heerdt, and A. Velcich Short Chain Fatty Acids and Colon Cancer J. Nutr., December 1, 2002; 132(12): 3804S - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, A. Velcich, J. Mariadason, C. Nicholas, G. Corner, M. Houston, W. Edelmann, R. Kucherlapati, P. R. Holt, and L. H. Augenlicht p21WAF1/cip1 Is an Important Determinant of Intestinal Cell Response to Sulindac in Vitro and in Vivo Cancer Res., August 1, 2001; 61(16): 6297 - 6302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mariadason, M. Bordonaro, F. Aslam, L. Shi, M. Kuraguchi, A. Velcich, and L. H. Augenlicht Down-Regulation of {beta}-Catenin TCF Signaling Is Linked to Colonic Epithelial Cell Differentiation Cancer Res., April 1, 2001; 61(8): 3465 - 3471. [Abstract] [Full Text] |
||||
![]() |
James. R. Gum Jr., James. W. Hicks, A. M. Gillespie, J. L. Rius, P. A. Treseler, S. C. Kogan, E. J. Carlson, C. J. Epstein, and Y. S. Kim Mouse Intestinal Goblet Cells Expressing SV40 T Antigen Directed by the MUC2 Mucin Gene Promoter Undergo Apoptosis upon Migration to the Villi Cancer Res., April 1, 2001; 61(8): 3472 - 3479. [Abstract] [Full Text] |
||||
![]() |
W. C. Yang, J. Mathew, A. Velcich, W. Edelmann, R. Kucherlapati, M. Lipkin, K. Yang, and L. H. Augenlicht Targeted Inactivation of the p21WAF1/cip1 Gene Enhances Apc-initiated Tumor Formation and the Tumor-promoting Activity of a Western-Style High-Risk Diet by Altering Cell Maturation in the Intestinal Mucosa Cancer Res., January 1, 2001; 61(2): 565 - 569. [Abstract] [Full Text] |
||||
![]() |
J. M. Mariadason, G. A. Corner, and L. H. Augenlicht Genetic Reprogramming in Pathways of Colonic Cell Maturation Induced by Short Chain Fatty Acids: Comparison with Trichostatin A, Sulindac, and Curcumin and Implications for Chemoprevention of Colon Cancer Cancer Res., August 1, 2000; 60(16): 4561 - 4572. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |